CSI Market
Sign In | Register

Verve Therapeutics Inc (VERV) Annual Balance Sheets

Annual · GAAP · USD millions
Access VERV quarterly Balance Sheets →
Tracking balance sheet results across Verve Therapeutics Inc to helps illustrate how Dec 31 2024's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent172.56
Marketable Securities, Current SH351.72
Cash & Short-term Investments523.00
Other Current Assets3.26
Prepaid Expense And Other Assets Current15.22
Total Current Assets542.75
Equipment/Property/Plant Net18.64
Other Assets, Noncurrent5.00
Collaboration Receivable3.26
Restricted Cash Noncurrent4.77
Operating Lease Right Of Use Asset78.08
Total Assets647.39
Liabilities
Accounts Payable, Current AC4.52
Accrued Liabilities, Current AC24.34
Other Liabilities, Current10.44
Deferred Revenue, Current DE3.61
Total Current Liabilities42.91
Total Long-term Debt0.00
Deferred Revenue and Credits, Noncurrent LI50.27
Other liabilities, Noncurrent60.82
Operating Lease Liability Current10.44
Operating Lease Liability Noncurrent59.54
Success Payment Liability1.18
Total Liabilities153.99
Stockholders' Equity
Common Stock Value0.09
Additional Paid In Capital Common Stock1,235.90
Retained Earnings / Accumulated Deficit-743.01
Other Equity0.43
Common Stockholder's Equity493.40
Total Stockholder's Equity493.40
Liabilities & Stockholder's Equity647.39
4 historic quarters locked

Sign in to unlock the full Verve Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Verve Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20241231)
  • Filed with the SEC: February 27, 2025
  • Source: verv-20241231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-028376

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License